合肥恩瑞特药业

Hefei Enrite Pharmaceutical is a China-based pharmaceutical company that focuses on the development, manufacturing, and sale of high-quality chemical drugs. Established in 2011, the company has built a robust portfolio centered on therapeutic areas such as gastroenterology, cardiovascular diseases, and anti-infectives. Its flagship products, including Rabeprazole Sodium and Clopidogrel Bisulfate, are key players in the domestic market for treating acid-related disorders and preventing atherothrombotic events. The company operates advanced manufacturing facilities in the Hefei High-tech Zone that adhere to national GMP standards. Hefei Enrite is recognized for its integration of R&D and production, aiming to provide affordable and effective medical solutions to the healthcare market.